3-Amino-6-bromopyrazine-2-carboxamide

Catalog No. :
ACDUPI714
CAS No. :
17890-77-6
Molecular Formula :
C5H5BrN4O
Molecular Weight :
217.03

IUPAC Name:3-amino-6-bromopyrazine-2-carboxamide

3-Amino-6-bromopyrazine-2-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$65.00Login to see priceIn stockInquiry
10g97%$119.00Login to see priceIn stockInquiry
25g97%$226.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Amino-6-bromopyrazine-2-carboxamide
IUPAC Name3-amino-6-bromopyrazine-2-carboxamide
MDL No.MFCD13689185
Molecular FormulaC5H5BrN4O
Molecular Weight217.03
SMILESNC(=O)C1=C(N)N=CC(Br)=N1
InChI KeyPBCURFNSKTTYGF-UHFFFAOYSA-N
SynonymQ-103298 | 3-Amino-6-bromo-pyrazine-2-carboxylic acid amide | DTXSID30332881 | MFCD13689185 | DS-13006 | SCHEMBL617348 | FT-0686912 | 2-Pyrazinecarboxamide, 3-amino-6-bromo- | PBCURFNSKTTYGF-UHFFFAOYSA-N | SY106913 | AKOS015909834 | SCHEMBL13353985 | p-Me
CAS No.17890-77-6
PubChem CID470899

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACDUPI714 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYHCP390 route compound structure diagram
    ACYHCP39032587-10-3 In Stock
  4. Then
  5. ACDUPI714 route product structure diagram
    ACDUPI71417890-77-6 In Stock
Inquiry

2. ACDUPI714 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACDUPI714 route product structure diagram
    ACDUPI71417890-77-6 In Stock
Inquiry

Comments (0)